The European Medicines Agency recommends contra-indicating the combination of aliskiren with an angiotensin-converting enzyme (ACE) inhibitor or with an angiotensin receptor blocker (sartan) to treat high blood pressure in patients with diabetes or kidney problems. The EMA also advises against this association in other patients.
More information on the EMA website.
Contact